透過您的圖書館登入
IP:18.188.70.255
  • 期刊

102-104年度中藥製劑之重金屬調查

Investigation of Heavy Metals in Chinese Medicinal Preparations, 2013-2015

摘要


為了解台灣中藥製劑中重金屬含量之現況,本計畫於102 - 104年間收集中藥製劑包括濃縮製劑、傳統單方製劑及傳統複方製劑共516件,以感應耦合電漿質譜儀(ICP/MS)檢測中藥製劑中鉛、鎘、汞、砷及銅等五種元素含量。檢測結果顯示341件濃縮製劑均符合限量規範標準,149件傳統複方製劑有8件檢品之重金屬含量偏高,超出率為5.4%。本結果已提供行政管理單位制訂或修正限量標準及管理之參考。

關鍵字

感應耦合電漿質譜儀 重金屬 中藥製劑

並列摘要


In order to survey the contents of heavy metals of Chinese medicinal preparations in Taiwan, 516 samples including concentrated Chinese medicinal preparations, traditional single herbal preparations and traditional multiple herbal preparations were collected during 2013-2015. The amounts of lead (Pb), cadmium (Cd), mercury (Hg), arsenic (As) and copper (Cu) in the Chinese medicinal preparations were determined by inductively coupled plasma mass spectrometry (ICP/MS). The results indicated that all 341 concentrated Chinese medicinal preparations met the required tolerance limits, and 8 of 149 (5.4%) traditional multiple herbal preparations contained higher levels of heavy metals. This survey provided reference to set up or revise the tolerance limit of heavy metals for the administration authority.

並列關鍵字

ICP/MS heavy metals Pb Cd Hg As Cu Chinese medicinal preparations

延伸閱讀


  • 謝佳霖、盧芬鈴、劉宜祝、施養志(2013)。中藥製劑之重金屬調查食品藥物研究年報(4),236-243。https://www.airitilibrary.com/Article/Detail?DocID=22195718-201311-201409230017-201409230017-236-243
  • 岳宗漢、張淑涵、王博譽、陳玉盆、周秀冠、施養志、陳惠芳(2014)。102年度國內藥廠原料之品質背景值調查食品藥物研究年報(5),139-149。https://www.airitilibrary.com/Article/Detail?DocID=22195718-201412-201501050013-201501050013-139-149
  • 傅孝瑜、黃守潔、陳玉盆、周秀冠、陳惠芳(2015)。102至103年度市售化粧品中微生物之品質監測食品藥物研究年報(6),288-294。https://www.airitilibrary.com/Article/Detail?DocID=22195718-201512-201601110026-201601110026-288-294
  • 蔡麗瑤、李蕙君、陳品秀、黃昱綺、顏宥幃、蔡佳芬、陳玉盆、周秀冠、王德原、陳惠芳(2017)。104及105年度食品摻加西藥檢驗案件分析食品藥物研究年報(8),76-86。https://www.airitilibrary.com/Article/Detail?DocID=22195718-201711-201801120009-201801120009-76-86
  • 陳儀驊、盧芬鈴、劉宜祝、施養志、羅吉方(2012)。Survey on Heavy Metals in Raw Materials of Traditional Chinese Medicine (VIII)食品藥物研究年報(3),373-384。https://doi.org/10.6945/ARFDR.201212.0373